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Abstract
Introduction—Penile erection is a hemodynamic process, which results from increased flow and
retention of blood in the penile organ due to the relaxation of smooth muscle cells. Adenosine, a
physiological vasorelaxant, has been shown to be a modulator of penile erection.
Aim—To summarize the research on the role of adenosine signaling in normal penile erection and
erectile disorders.
Main Outcome Measures—Evidence in the literature on the association between adenosine
signaling and normal and abnormal penile erection, i.e., erectile dysfunction (ED) and priapism.
Methods—The article reviews the literature on the role of endogenous and exogenous adenosine
in normal penile erection, as well as in erectile disorders namely, ED and priapism.
Results—Adenosine has been shown to relax corpus cavernosum from various species including
human in both in vivo and in vitro studies. Neuromodulatory role of adenosine in corpus cavernosum
has also been demonstrated. Impaired adenosine signaling through A2B receptor causes partial
resistance of corpus cavernosum, from men with organic ED, to adenosine-mediated relaxation.
Increased level of adenosine has been shown to be a causative factor for priapism.
Conclusion—Overall, the research reviewed here suggests a general role of exogenous and
endogenous adenosine signaling in normal penile erection. From this perspective, it is not surprising
that impaired adenosine signaling is associated with ED, and excessive adenosine signaling is
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associated with priapism. Adenosine signaling represents a potentially important diagnostic and
therapeutic target for the treatment of ED and priapism.
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Introduction
The tone of arterial and cavernous smooth muscle cells is a key regulator of penile erection,
and is determined by the balance of relaxants and constrictors [1]. Nitric oxide (NO) is the
principal mediator of penile erection [2], but that does not exclude a role of other signaling
molecules, either released by neurons, and/or endothelial and smooth muscle cells in the
regulation of the process.
One such mediator is adenosine. Adenosine triphosphate (ATP) and its metabolite, adenosine
have long been of interest as modulators of penile erection [3]. Considerable work has been
carried out to show that ATP and especially adenosine act as relaxants of corpus cavernosa in
vitro [4–7]. Recent work has revealed novel roles of adenosine in penile function, such as a
modulator of adrenergic neurotransmission, and a causative factor for erectile disorder called
priapism [8,9]. In light of these interesting discoveries, it is necessary to critically look at the
research on the role of adenosine signaling in erectile physiology. This review starts with a
brief introduction of penile physiology and adenosine metabolism, followed by an extensive
overview of adenosine signaling in penile erection and erectile disorders.
Physiological Control of Penile Erection and Flaccidity
Anatomy of Penile Organ
The penis contains three cylindrical tissues: the ventral corpus spongiosum and dorsally a pair
of corpus cavernosum [10]. The corpus cavernosum (CC) contains open spaces called
sinusoids, which are surrounded by smooth muscle cells [11,12]. Blood is supplied to the CC
by cavernous arteries, which penetrate the tunica albuginea and enter the CC. Cavernosal
arteries branch into resistant arteries called helicine arteries, which feed directly into sinusoidal
spaces. The blood from the sinusoids is drained into subtunical venules that coalesce just
beneath the tunica albuginea [12,13].
Penile flaccidity and erection are regulated by multiple cellular systems including neuronal,
vascular, endothelial, and smooth muscle cells.
Regulation of Penile Flaccidity
Generally, for about 23 hours of the day, the penis in most men is in the flaccid state [14].
During this state, smooth muscle cells of penile arteries and CC are contracted. The flaccidity
is mainly maintained by tonic release of noradrenaline through the rich sympathetic innervation
of penile smooth muscles. Noradrenaline contracts smooth muscle cells in penile arteries and
CC, thereby increasing vascular resistance and collapsing sinusoidal spaces, respectively [3].
Regulation of Penile Erection
During penile erection, vascular smooth muscle relaxation decreases vascular resistance,
thereby increasing blood flow through cavernous and helicine arteries, filling sinusoids, which
are expanded due to the relaxation of smooth muscle cells in the CC. This results in an increase
in intracavernosal pressure and compression of subtunical veins against tunica albuginea,
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thereby restricting outflow of blood from CC and entrapping pressurized blood in the CC
[12].
Even though NO, released during nonadrenergic, noncholinergic (NANC) neurotransmission
and from endothelium, is the principal relaxant of the penile smooth muscle cells, multiple
other factors, either neuronal or vascular in origin, have also been shown to modulate penile
erection [3,15–18]. Adenosine, like NO, is a potent vasodilator and has long been implicated
in the regulation of penile erection.
Adenosine Metabolism
Adenosine is formed continuously by degradation of adenine nucleotides, intracellularly and
extracellularly. Under normal physiological conditions, intra- and extracellular levels of
adenosine are in nanomolar range, but they rise into millimolar concentrations under stressful
conditions like hypoxia, ischemia, and cellular damage. Intracellularly, adenosine is formed
predominantly by dephosphorylation of adenosine monophosphate (AMP), catalyzed by
intracellular 5′-nucleotidase. Hydrolysis of s-adenosyl-homocysteine also contributes to
intracellular adenosine formation [19]. Inside the cell, adenosine is catabolized by two
enzymes, adenosine kinase (ADK) and adenosine deaminase (ADA). ADK phosphorylates
adenosine to AMP, and is critical for regulating intracellular levels of adenosine and
maintaining intracellular levels of nucleotides. ADA catalyses irreversible conversion of
adenosine to inosine. Under normal conditions, ATP is degraded to adenosine, but under
cellular stress ATP degradation increases. Intracellular adenosine homeostasis is also
maintained by bi-directional equilibrative nucleoside transporters (ENT) in the plasma
membrane, through facilitated diffusion of adenosine in the direction of concentration gradient
[19]. Adenosine is also generated extracellularly by degradation of adenine nucleotides. ATP
is released from neurons as neurotransmitters, and also released from cells through connexin
hemichannels, and when the cell membrane is subjected to mechanical stress [20]. Intracellular
ATP levels are in millimolar range; hence, when the cell membrane is damaged, extracellular
ATP levels increase. Extracellular adenine nucleotides are dephosphorylated by
ectonucleotidases. Ectonucleotidases such as CD39, hydrolyse ATP and ADP to AMP. Ecto-5′-
nucleotidase (CD73) catalyses dephosphorylation of AMP to adenosine [21]. Extracellular
adenosine is transported into the cells through ENT, depending upon concentration gradient,
and is also degraded to inosine by extracellular ADA [19]. Adenosine metabolism is depicted
in Figure 1.
Role of Adenosine in Penile Erection
Many studies, both in vivo and in vitro, implicating adenosine as a modulator of penile erection
in multiple species, will be reviewed in this section and are summarized in Table 1.
In Vivo Studies
Studies in dog showed that intracavernous injection of adenosine (0.67–15 μg/kg B.W.)
induced a full erection, which was independent of acetylcholine effect [25]. Consistently,
Takahashi et al. [26] further investigated the hemodynamic effect of intracavernous injection
of adenosine in dogs. They found that adenosine increased arterial blood flow and
intracavernous pressure (ICP) thereby inducing penile erection in a dose dependent manner
(10–100 μg) [26]. Adenosine-mediated increased ICP was potentiated by pretreatment with
equilibrative nucleoside transporter inhibitor (dipyridamole at 100 μg) and was significantly
decreased by nonselective adenosine receptor antagonist theophylline at 1 mg [26]. These
studies indicate that adenosine is capable of inducing penile erection via its receptor.
Subsequently, Takahashi et al. [26] further observed that upon intracavernous co-injection of
adenosine (minimum dosage to increase ICP: 27.8 μg) and acetylcholine (minimum dosage to
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increase ICP: 9.5 μg) the erectile effects were synergistic but not additive. These findings imply
that adenosine-mediated penile erection is likely via a different mechanism from that of
acetylcholine. Noto et al. [27] also reported dose-dependent increase in ICP upon
intracavernous adenosine injection (0.1–1 mM). This increase in ICP was abolished by
pretreatment with 8-(p-sulfophenyl) theophylline (8-SPT; 0.1 mM), a nonspecific adenosine
receptor antagonist. Overall, these studies demonstrate that adenosine is capable of inducing
penile erection via adenosine receptor signaling.
In Vitro Studies
Wu et al. [4] reported adenosine induced relaxation of CC of rabbit, both under base-line tension
and precontraction (0.1–1 mM). This observation was substantiated by multiple other studies
in rabbit [6,22–24]. More importantly, Chiang et al. [24] observed inhibition of nerve
stimulated contraction of corpus cavernous strips of rabbit by adenosine and its analogs (5′-N-
ethyl-carboxamidoadenosine [NECA] or R-phenylisopropyl-adenosine) in a dosage-
dependent way (from 10−5 to 10−2 M). In this study, the authors also reported inhibition of
noradrenaline-induced contraction of corpus cavernosum by adenosine and its analogs. Thus,
these studies indicate that adenosine, a potent vasodilator, induces CC relaxation under
cavernosal nerve stimulation. Supporting this finding, Mantelli et al. [6] found adenosine (3
μM–3 mM) to be more potent relaxant than acetylcholine in rabbit corpus cavernous strips as
adenosine completely relaxed the precontracted corpus cavernous strips (CCS), while
acetylcholine did not. In agreement with Mantelli et al. [6], Filippi et al. [7] observed that
adenosine relaxed the precontracted human CCS in a dosage dependent manner and the highest
concentration (3 mM) almost completely relaxed the tissue. Similarly, adenosine (100 μM)
and its analogs (such as NECA 10 μM) have also been found to induce relaxation in CCS from
humans and mice [7–9,28,29].
Taken together, both in vitro and in vivo studies demonstrate that adenosine is capable of
inducing relaxation in CC and even erection in multiple species.
Role of Adenosine Receptors in Penile Erection
Extracellular adenosine affects physiological processes by signaling through four different
receptors; A1, A2A, A2B, and A3. All four receptors are G-protein coupled. A1 and A3 couple
to inhibitory G-protein, Gi, to inhibit adenylyl cyclase that results in decreased cyclic AMP
[30] levels, intracellularly. A2A and A2B couple to stimulatory G-protein, Gs, to activate
adenylyl cyclase that results in increased cyclic AMP (cAMP) levels intracellularly [19]. The
expression of adenosine receptors in penile tissue and the role of adenosine signaling via its
receptor in penile physiology will be thoroughly reviewed in this section.
Expression of Adenosine Receptors in Corpus Cavernosum
There are limited studies available to directly characterize adenosine receptor expression
profile in CC. Filippi et al. [7] demonstrated the presence of the A2 adenosine receptors in
human CC by employing binding studies, which is by far the only attempt to characterize the
adenosine receptors in penis using this method. Filippi et al. [7] used 125I-labeled 2-[4-(2-[2-
[(4-aminophenyl)methyl carbonylamino]ethylaminocarbonyl]-ethyl) phenyl]ethylamino-5′-
N-ethylcarboxamidoa denosine ([125I] PAPA-APEC), an A2 selective agonist to characterize
A2 receptors in Human CC. They found a single class of high affinity, low capacity binding
sites. In a competition binding experiment PAPA-APEC binding was completely displaced by
adenosine and an A2a selective agonist CGS21680. In this study, the author reported that
CGS21680 shows higher affinity than adenosine. This binding profile fits the presence of
A2a receptors at a low density.
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Employing real-time polymerase chain reaction technique, Mi et al. [9] showed A2B to be the
predominant receptor subtype, expressed in corpus cavernous smooth muscle cells of mice at
an mRNA level. Relatively low-level expression of A2A was detected, while mRNA of A1 and
A3 were nondetectable. More work needs to be done employing techniques, such as
immunohistochemistry and western-blot, to study the expression profile of receptor subtypes
in constituent cells as well as in whole organ at a protein level, which is functionally more
relevant.
Adenosine Receptors Involved in Adenosine Induced Relaxation of Corpus Cavernosum
There is a sizable amount of work employing pharmacological tools to identify, which
adenosine receptor is involved in adenosine mediated relaxation of CC. For example, Mantelli
et al. [6] reported that relaxant effect of exogenously added adenosine in rabbit CC is mediated
by activation of A2 receptors, which was further substantiated by numerous studies in multiple
species [7–9,22,27–29]. Based on the potency of receptor subtype specific agonist and the
effect of receptor subtype specific antagonists, Mantelli et al. [6] suggested involvement of
A2A receptor in adenosine induced relaxation of rabbit CC. Filippi et al. [29] and Noto et al.
[27] also implicated a role of A2A in adenosine induced relaxation in CC of rabbit and dog,
respectively.
In human, Faria et al. [28] demonstrated involvement of A2 receptors in adenosine induced
relaxation of human CC, using A2 subtype selective agonists and antagonists. An A2A selective
agonist (CGS21680c), at saturation concentration, could induce about 50% of the maximum
relaxation induced by adenosine analog, NECA, a nonselective adenosine receptor agonist.
The relaxation caused by NECA was significantly inhibited by pretreatment of human CCS
with A2B selective antagonist (MRS1706), but had no significant effect on the relaxation
induced by A2A selective agonist (CGS21680c). Pretreatment with an A2A selective antagonist
(ZM241385), with an appreciable affinity for A2B, significantly inhibited relaxation caused by
both, A2A selective agonist (CGS21680c) and NECA. Based on these results, the authors
suggested involvement of both, A2A and A2B receptors in adenosine induced relaxation of
human CC [28]. This observation is very much in agreement with the one reported by Tostes
et al. [8], who also observed adenosine induced relaxation in mouse CC to be mediated through
activation of both, A2A and A2B receptors.
In addition to pharmacological approaches, genetic studies have recently been performed by
Mi et al. [9]. In this study, using adenosine receptor deficient mice, Mi et al. [9] observed
complete absence of adenosine mediated relaxation in CCS from A2B receptor knockout mice,
while CCS from A1,A2A, and A3 knockout mice and wild type mice showed a dose-dependent
increase in relaxation. Thus, both genetic and pharmacological studies provide strong evidence
that adenosine induced relaxation of CC is mediated through A2 receptors in multiple species.
Adenosine Receptors Involved in Adenosine Mediated Neuromodulation in Corpus
Cavernosum
Adenosine modulates release of neurotransmitters as well as their effects, both in the central
and peripheral nervous system [31]. This neuromodulatory role of adenosine has been
demonstrated in CC of different species.
In an in vivo study in dogs, Takahashi et al. [25] found the cavernous nerve stimulation induced
erectile response to be enhanced by pretreatment with ENT inhibitor, dipyridamole, and was
reduced by pretreatment with nonselective adenosine receptor antagonist theophylline. This
observation along with the finding that upon intracavernous co-injection of adenosine and
acetylcholine, the pro-erectile effects were synergistic, but not additive, prompted Takahashi
et al. [25] to propose that adenosine plays a cooperative role with acetylcholine, and that it has
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a physiological role as a neuromodulator in canine penile erection. In agreement with the results
of Takahashi et al. [25], Mi et al. [9] reported that reducing the adenosine levels in vivo by
ADA injection, resulted in a significant decrease in electric field stimulation (EFS) induced
relaxation of CCS of mice. The results reported by Chiang et al. [24] further supported the role
of adenosine as a neuromodulator in a penile erection. In this study, adenosine and its analogs
inhibited nerve stimulated contraction of CCS of rabbit. Based on the potency order, the authors
suggested involvement of A2 receptor signaling in the neuromodulation. In support of their
conclusion, Chiang et al. [24] observed that A2 receptor antagonist abolished EFS induced
relaxation. Chiang et al. [24] also reported inhibition of noradrenaline induced contraction of
CC by adenosine and its analogs. Based on these results, Chiang et al. [24] indicated that
modulation of adrenergic effects by adenosine in CC is through post-junctional receptors. The
rank order of potency of adenosine and its analogs in inhibiting noradrenaline- and EFS-
induced contraction of CC, and the observation that A2 receptor antagonist abolished EFS
induced relaxation, but A2A selective agonist, had no effect on noradrenaline induced
contraction, led the authors to conclude that the adenosine receptor involved in
neuromodulation of relaxation of rabbit CC is of A2B type.
In contrast to Chiang et al. (1994), Tostes et al. [8] showed the involvement of A1 receptor in
the modulation of neuronally induced contraction by endogenous adenosine. Endogenously
generated adenosine was found to inhibit EFS induced contraction, which was sympathetic in
origin and adrenergic in nature, in mouse CCS. Both, A2A and A2B receptors were found to
have no role in neuronal modulation. On the other hand, A1 receptor selective antagonist
abolished the inhibitory effect of endogenous adenosine. Adenosine is known to inhibit release
of noradrenaline from sympathetic nerves through activation of presynaptic A1 receptors
[32,33]. A direct experimental evidence for adenosine-mediated inhibition of noradrenaline
release in CC, will unequivocally establish neuromodulatory role of adenosine in penile
erection.
Adenosine Mediated Intracellular Signaling in Corpus Cavernous Relaxation
Adenosine is a potent endogenous vasodilator. Adenosine induced vasodilation is considered
to be mediated by increasing intracellular cyclic AMP [30] levels in vascular smooth muscle
cells through A2 receptor signaling [34]. The section below will review the intracellular
signaling mechanisms involved in adenosine mediated smooth muscle relaxation and penile
erection by focusing on two key intracellular second messengers, cAMP and cyclic guanosine
monophosphate (cGMP). cAMP and cGMP activate their respective downstream protein
kinases, protein kinase A (PKA) and protein kinase G (PKG), which in turn phosphorylate
their downstream targets, resulting in a decrease in intracellular Ca+2 concentration, leading
to smooth muscle relaxation [35]. PKG also contributes to smooth muscle relaxation, by
phosphorylating RhoA and inhibiting RhoA-Rho kinase signaling pathway, an important
signaling mechanism involved in mediating smooth muscle contraction in penis [35,36].
Working model of adenosine mediated intracellular signaling in CC is shown in Figure 2.
Adenosine Induced cAMP in Corpus Cavernosum via Adenosine Receptor
Activation—Using genetic approaches, Mi et al. [9] demonstrated that adenosine through
A2B receptor leads to cAMP induction in mouse CC. Consistent with genetic findings, the
authors observed that EFS induced cAMP generation in mouse CC is completely blocked by
A2B receptor antagonist [9]. Finally, the authors demonstrated that adenosine-mediated cAMP
induction was completely abolished in the corpus cavernosal smooth muscle cells (CCSMCs)
purified from A2B receptor deficient mice. Pharmacological studies further supported the
genetic finding that adenosine-mediated cAMP induction is via A2B receptor signaling in
CCSMCs [9].
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Role of NO and cGMP in Adenosine Induced Relaxation of Corpus Cavernosum
—Adenosine induced vasodilation is considered to be endothelium independent. However,
accumulating evidence indicates a role of endothelium derived NO in adenosine induced
vasodilation [37–39]. Adenosine induces NO synthesis in endothelial cells through A2 receptor
signaling [40–43]. Few studies have demonstrated the role of NO signaling in adenosine
mediated CCS relaxation. For example, in human CC, Faria et al. [28] reported that adenosine-
mediated CC relaxation is partially dependent on endothelial derived NO, and induction of NO
synthesis is most likely mediated through A2B receptor signaling. In rabbit, Chiang et al. [24]
also indicated that adenosine induced relaxation in CCS is partly endothelium dependent. In
addition to these studies, we have recently provided both, genetic and pharmacological
evidence for adenosine induced generation of cGMP, the down-stream second messenger of
NO signaling, via A2B receptor in mouse CCS. However, adenosine does not stimulate cGMP
generation in CCSMCs, suggesting that in the CC of mice adenosine may induce NO synthesis
in non muscle cells, and the possible cellular target may be the endothelial cells [9]. Using EFS
to mimic normal, physiological penile erection, the authors further found that EFS-induced
cGMP generation in mouse CCS is also partially dependent upon A2B receptor signaling in a
NO dependent manner [9]. This observation suggests that endogenous adenosine may play a
part in facilitating mouse penile erection. Based on the above information, adenosine induced
relaxation of CC may partly depend upon NO synthesis, most probably mediated through
A2B receptors on the endothelial cells.
Thus, exogenous and endogenous adenosine through A2B receptor mediates induction of both,
cAMP and cGMP synthesis in mouse CC, but the cellular targets are different. It is important
to determine how much each signaling cascade, cAMP and cGMP, triggered by adenosine,
contributes to smooth muscle relaxation and eventually penile erection.
Role of Adenosine in ATP Induced Corpus Cavernous Relaxation
After the suggestion that NANC neurotransmission plays a role in penile erection [44], and
before it was established that NO was the major NANC neurotransmitter [45], a lot of interest
was generated in ATP, as a potential candidate for NANC neurotransmitter in penile tissue, in
the early 90s. ATP was described earlier, as a potential NANC neurotransmitter [46,47]. A
sizeable amount of work has been carried out to evaluate the modulatory role of ATP in penile
erection [4,5,22,23,27,29,48–52]. In many studies, relaxant effects of ATP on CC were found
to be attributable to its metabolite, adenosine. For example, Ragazzi et al. [23] observed the
ATP induced relaxation in rabbit CC to be independent of P2Y receptor signaling, which is
known to mediate vasorelaxation by ATP [53,54]. This observation, along with the fact that
in the same study adenosine concentration dependently induced relaxation of precontracted
CC, prompted the authors to hypothesize that the effects of ATP were mediated by adenosine,
derived from ATP metabolism, acting through adenosine receptors. Similarly, Filippi et al.
[29] also reported that the smooth muscle relaxant effect of ATP in rabbit CC is partly mediated
by adenosine acting through A2A receptors. The role of adenosine in ATP induced relaxation
of penile tissue is supported by yet another study [27]. The work was carried out in vivo in
dogs. Tumescence upon intracavernous injection of ATP was abolished by pretreatment with
8-SPT, a nonspecific adenosine receptor antagonist, indicating that adenosine derived from
metabolic breakdown of ATP was responsible for the relaxing effect of ATP [27]. Overall,
evidence from multiple studies demonstrates that part of the relaxant effect of ATP in CC is
mediated by its metabolite adenosine.
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Role of Adenosine Signaling in Erectile Disorders
Along with normal penile erection, adenosine signaling has also been found to be critical in
erectile disorders, viz. erectile dysfunction (ED) and priapism. Studies evaluating role of
adenosine signaling in erectile disorders are summarized in Table 2.
ED
ED is characterized by the inability to develop or maintain an erection sufficient to permit
satisfactory sexual intercourse [17]. Based on the causes, ED is classified into psychogenic
and organic. Causes of organic ED could be neurogenic, hormonal, or vasculogenic in nature.
Organic ED could also be a result of aging or other systemic disease such as diabetes and
chronic renal failure [17].
Response of ED Corpus Cavernosum to Adenosine—Few studies have been carried
out to evaluate the response of CC, from men with organic ED and CC from animal models
for diseases, which lead to ED, to adenosine [28,55–58]. Gur and Ozturk [56] studied the
response of CC from diabetic and non-diabetic impotent men. They observed enhanced
sensitivity of CC from diabetic men to adenosine-induced relaxation compared to CC from
non-diabetic men. An enhanced response, but not sensitivity to adenosine was noted in diabetic
rats compared to nondiabetic rats. The extent of relaxation induced by adenosine in CC from
men with and without diabetes was greater than in rats with and without diabetes [56]. The
authors suggest a greater role as a modulator for adenosine in human CC than in the corporeal
tissue of rats [56]. Carneiro et al. [57] reported preservation of adenosine induced relaxation
in CC from an obese and type II diabetic mouse compared to control, but did not observe any
enhancement. Their results are in agreement with Ayan et al. [55], who observed similar results
in CC from diabetic rabbits and controls. This group [57], in agreement with their earlier report
on the neuromodulatory role of adenosine in CC of mouse [8], further observed inhibition of
contractile response in CC, induced by electric stimulation of adrenergic nerves, by endogenous
adenosine through A1 receptor in the obese and diabetic mouse. The results reported by
Carneiro et al. [57] are also in agreement with Kilicarslan et al. [58], who also observed
adenosine induced relaxastion of CC of rabbit to be unchanged by chronic renal failure. Similar
results were also reported in CC of hypothyroid rabbits with significantly reduced levels of
testosterone [60]. It is interesting to note that additional testosterone therapy shows no effect
on the response of CC to adenosine in rabbit [62]. In all these conditions, diabetes, chronic
renal failure, and hypothyroidism, impairment of nonadrenergic noncholinergic
neurotransmission and endothelial dysfunction seem to contribute toward ED [57,58,60], but
adenosine induced relaxation of CC is preserved, indicating a potential therapeutic role for
adenosine.
In contrast to the above studies, Faria et al. [28] observed partial resistance of CC from men
with vasculogenic impotence to adenosine induced relaxation and showed that dysfunctional
A2B receptors, supposedly on the endothelium, are the cause for the signaling impairment.
They suggested targeting A2A receptors, supposedly on the smooth muscle cells, as a treatment
for vasculogenic ED.
Adenosine as a Treatment for ED—Adenosine, due to its vasorelaxant properties, has
always been looked upon as a potential treatment for ED. Chiang et al. [24] evaluated potential
of adenosine as a treatment for ED. They observed that intracorporeal injection of adenosine
in impotent men caused increased cavernosal arterial flow and resulted in tumescence or
suboptimal erection, but failed to cause full erection, while intracorporeal injection of
prostaglandin E1 (PGE1) was able to do so. These results are partly in agreement with Kilic
et al. [59], who evaluated the potential of adenosine as an agent in the diagnosis of vasculogenic
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impotence. Kilic et al. [59] did not even observe any changes in cavernosal arterial blood flow
at low to moderate dosage of intracavernous adenosine, and had to administer a very high dose
of adenosine to elicit a full erection. Both the studies detected no side effect upon adenosine
injection, and Kilic et al. [59] reported absence of fibrosis and curvature 6 months after the
injections. Chiang et al. [24] attributed the lack of erection upon adenosine injection to the
rapid degradation of adenosine, which was also the reason put forth by Kilic et al. [59] for the
short duration of erection caused by adenosine injection. Adenosine has a short half-life [63]
due to rapid degradation of extracellular adenosine by ADA [19]. Inhibition of ADA has been
shown to enhance adenosine-induced relaxation of mouse CCS [9]. Co-injection of an ADA
inhibitor with adenosine might improve its therapeutic potential. A different explanation was
provided by Filippi et al. [7] for the lack of effect of adenosine on penile erection. They
observed similar results as that of Chiang et al. [24]. Filippi et al. [7] experimentally
demonstrated that along with precontracted human CCS adenosine could also completely relax
noradrenaline contracted penile venous strips, while the effect of PGE1 on venous strips was
limited. The authors [7] suggest that the ability of adenosine to relax both penile arteries and
veins might impair the initial buildup of intracavernous pressure, thereby preventing
venoocclusion and ultimately erection.
Priapism
Priapism is characterized by a condition of persistent penile erection in the absence of sexual
stimulation and interest [64]. It is caused by disturbance of hemodynamic mechanisms in the
penis, which leads to the trapping of blood inside the organ [65]. About 40% of sickle cell
disease (SCD) patients display priapism, and SCD transgenic (Tg) mouse is an established
animal model to study the disorder [9,66–68]. Priapism is a painful pathological condition that
requires urgent medical attention as it carries a risk of fibrosis leading to permanent structural
damage to the penis and ultimately ED. Treatment options are limited due to the lack of
understanding of molecular mechanisms underlying the phenotype [69].
Excess Adenosine Contributes to Priapism—A serendipitous observation in our lab
revealed the role of adenosine signaling in priapism. Unexpected priapic phenotype in ADA
knock-out (ADA-/-) mice led to further investigation, which showed that priapism could be
corrected by ADA injections, thereby implying that higher level of adenosine caused prolonged
penile erection [9,61]. CCS from ADA-/- mice was more sensitive to EFS than CCS from wild
type mice with significantly more pronounced relaxation [9]. To identify, which adenosine
receptor is essential for adenosine mediated penile vascular relaxation, CCS relaxation in
adenosine receptor deficient mice in response to adenosine was measured. Adenosine induced
relaxation was completely absent in CCS from A2B–/– mice, but was not affected in other
adenosine receptor subtype deficient mice thus providing strong genetic evidence for the role
of A2B receptor [9]. To assess the general significance of high adenosine levels in the
pathophysiology of priapism, the potential contribution of excess adenosine to the priapism
associated with SCD was investigated. Like ADA-/- mice, the penis of SCD Tg mice also had
higher levels of adenosine than those of controls and CCS from SCD Tg mice were more
sensitive to EFS than those of controls. Treatment with ADA and A2B receptor antagonist,
individually, significantly reduced the force and duration of relaxation of CCS from SCD Tg
mice, thereby suggesting a general contributory role of elevated adenosine in priapism through
activation of A2B receptors and novel therapeutic possibility [9].
Polyethylene Glycol Modified ADA as a Potential Treatment for Priapism—To
establish the cause and effect relationship between enhanced level of adenosine and
development of priapism in ADA-/- mice, we regulated adenosine levels in ADA-/- mice by
injecting them intraperitoneally with different doses of polyethylene glycol modified ADA
(PEG-ADA). The mice on low dosage of PEG-ADA developed prolonged penile erection,
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which was quickly corrected by injection of a high dose of PEG-ADA [9,61]. This finding
provides an evidence for the first time that PEG-ADA, a safe drug, which has been used
successfully to treat both, human and mouse, with ADA deficiency [70,71], is likely a novel
effective therapeutic treatment for priapism.
Conclusion and Significance
Early studies hinted at a potential role for adenosine signaling in penile erection [8,24,25].
Attention has recently returned back to adenosine signaling with reports indicating that
impaired A2BR signaling is associated with ED in men [28] and excess adenosine contributes
to priapism via A2BR signaling in both, ADA-/- mice and SCD Tg mice [9]. Substantial
evidence suggests a general role for adenosine signaling in normal penile erection as
vasorelaxant and neuromodulator. From this perspective, it is not surprising that impaired
adenosine signaling is associated with ED [28] and excessive adenosine signaling is associated
with priapism [9]. Thus, adenosine signaling represents a potentially important therapeutic
target for the treatment of priapism and ED. Notably, the discovery of excess adenosine as the
causative factor for priapism in mice opens up the possibility of treating this painful disorder
with PEG-ADA enzyme therapy. In contrast, preservation of adenosine-induced relaxation in
CC of men with organic ED holds a great promise to evaluate adenosine as a potential
therapeutic treatment.
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Figure 1.
Adenosine metabolism. Adenosine is formed by degradation of adenine nucleotides,
intracellularly and extracellularly. Intracellularly, adenosine is formed predominantly by
dephosphorylation of adenosine monophosphate (AMP) by intracellular 5′-nucleotidase (cyto
5′NT), but hydrolysis of s-adenosyl-homocysteine (AdoHcy) by s-adenosyl-homocysteine
hydrolase (SAHH) also contributes. Inside the cell, adenosine is catabolized by two enzymes,
adenosine kinase (ADK) and adenosine deaminase (ADA). ADK phosphorylates adenosine to
AMP. ADA catalyses irreversible conversion of adenosine to inosine. Adenosine is also
generated extracellularly by degradation of adenine nucleotides. Ectonucleotidases such as
CD39 hydrolyse ATP and ADP to AMP. Ecto-5′-nucleotidase (CD73) catalyses
dephosphorylation of AMP to adenosine. Extracellular adenosine is degraded to inosine by
extracellular ADA. Adenosine homeostasis is maintained by bi-directional transport through
equilibrative nucleoside transporters (ENT) in the plasma membranes in the direction of
concentration gradient. Extracellular adenosine mediates signals through membrane anchored
G-protein coupled receptors (AR).
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Figure 2.
Working model of adenosine mediated intracellular signaling in corpus cavernosum.
Adenosine induces synthesis of both, cGMP and cAMP, in corpus cavernosum. cAMP
induction is mediated through A2B receptor on smooth muscle cells. Induction of cGMP by
adenosine is most possibly mediated by activation of nitric oxide (NO) synthesis in endothelial
cells through A2B receptor signaling. NO upon diffusing into smooth muscle cells may induce
cGMP. Both, cAMP and cGMP, activate their downstream kinases, PKA and PKG,
respectively, which in turn phosphorylate their downstream targets resulting in a decrease in
intracellular Ca+2 concentration that leads to smooth muscle relaxation. PKG also
phosphorylates RhoA and inhibits RhoA-Rho kinase signaling pathway, thereby contributing
to smooth muscle relaxation.
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Table 1
In-vivo and in-vitro studies evaluating the effect of adenosine on corpus cavernosum
Species In vitro/in vivo
study
Findings Reference
Mouse In vitro • Exogenously added adenosine relaxed precontracted corpus cavernosum (10–8–3 × 10–4 M) [8]
• Endogenous adenosine signaling inhibited electric field stimulated contraction of corpus
cavernosum (dypyramole:10–7–10–4 M; MRS1706: 10–7 M)
Mouse In vitro Exogenously added adenosine relaxed corpus cavernosum (10–8–10–2 M) [9]
• Reduction in endogenous level of adenosine with adenosine deaminase injection inhibited electric
field stimulated relaxation of precontracted corpus cavernosum (DCF: 5–100 mM)
Rabbit In vitro Exogenously added adenosine relaxed precontracted corpus cavernosum (3 mM–3 mM) [4,6,22,23]
Rabbit In vitro • Exogenously added adenosine relaxed precontracted corpus cavernosum (10–5–10–2 M) [24]
• Exogenously added adenosine inhibited electric field stimulated contraction of corpus cavernosum
(10–5–10–2 M)
Dog In vivo Intracavernous injection of adenosine induced a full erection (0.67–15 mg/kg body weight) [25]
Dog In vivo • Intracavernous injection of adenosine induced an increase in arterial blood flow (27.8 mg minimum
dose)
[26]
• Intracavernous injection of adenosine induced a full erection (27.8 mg minimum dose)
Dog In vivo Intracavernous injection of adenosine induced an increase in intracavernous pressure (1 mM) [27]
Human In vitro Exogenously added adenosine relaxed precontracted corpus cavernosum (IC50 = 2.38 ± 0.17 mM) [7,28,29]
Human In vivo Intracavernous injection of adenosine induced an increase in blood flow velocity but failed to induce
erection (6–600 μg)
[7]
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Table 2
Role of adenosine signaling in erectile disorders (including erectile dysfunction and priapism)
Description of model Findings Reference
Type I diabetic rabbit Preservation of the relaxant effect of adenosine in the corpus cavernosum of diabetic rabbit [55]
Type I diabetic rat Enhanced relaxant response to adenosine in the corpus cavernosum of diabetic rats compared
to the corpus cavernosum of control rat
[56]
Diabetic and non-diabetic
impotent men
Enhanced sensitivity of corpus cavernosum from diabetic men to adenosine induced relaxation
compared to corpus cavernosum from non-diabetic men
[56]
Obese and Type II diabetic (db/db)
mouse
Preservation of the relaxant effect of adenosine in the corpus cavernosum of db/db mouse [57]
Rabbit with Chronic renal failure
(CRF)
Preservation of the relaxant effect of adenosine in the corpus cavernosum of CRF rabbit [58]
Men with impotence Increased cavernosal arterial flow and induce partial penile erection upon intracorporeal
injection of adenosine (30–40 mg)
[24]
Men with impotence No change in cavernosal arterial blood flow at low doses of intracavernous injection of
adenosine (25–25-μg) and induction of penile erection only upon relatively very high doses of
intracavernous injection of adenosine (500–1000 μg or infusion at 120 μg/kg/minute for 10
minutes)
[59]
Men with vasculogenic impotence Partial resistance of corpus cavernosum to adenosine induced relaxation due to dysfunctional
A2B receptor
[28]
Hyperthyroid rabbit Preservation of the relaxant effect of adenosine in the corpus cavernosum of hyperthyroid rabbit [60]
Adenosine deaminase deficient
mouse (ADA–/–)
ADA-enzyme therapy correct spontaneously prolonged penile erection quickly (5 u PEG-ADA
injection); Both PEG-ADA (2–20 u) and A2BR antagonist, MRS1706 (1–10 μM) inhibit
cavernosal relaxation induced by electrical field stimulation
[9,61]
Sickle cell disease transgenic
mouse
Both PEG-ADA (2–20 u) and A2BR antagonist, MRS1706 (1–10 μM) inhibit cavernosal
relaxation induced by electrical field stimulation
[9,61]
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